CJC-1295 no DAC + Ipamorelin 10 MG
CJC-1295 no DAC + Ipamorelin 10 MG is a research peptide blend that combines two distinct growth-hormone-axis tools. CJC-1295 without DAC, also referenced as Modified GRF (1-29), is a short-acting analog of growth-hormone-releasing hormone (GHRH) that binds the GHRH receptor on somatotroph cells. Ipamorelin is a selective pentapeptide growth-hormone secretagogue that acts through the ghrelin/GHS-R1a receptor pathway, modeling a mechanism distinct from but complementary to GHRH signaling. Together the two compounds engage parallel receptor systems implicated in pulsatile growth-hormone release. In laboratory settings, researchers study this pairing to characterize receptor-binding behavior, intracellular cAMP signaling, and the in-vitro secretory dynamics of cultured pituitary cells. Comparative work examines how GHRH-receptor and GHS-R1a agonism interact at the molecular level, alongside structure-activity relationships, peptide stability, and assay reproducibility. Such studies are confined to cell-based and preclinical models for mechanistic and analytical purposes. Peptiva Research Labs supplies it as a research-grade reference compound, HPLC-verified with a COA available. For Research Use Only, not for human or veterinary use.
Read the research guide: CJC-1295 (No DAC) + Ipamorelin Blend: Research Overview →
Frequently asked questions
What is CJC-1295 no DAC + Ipamorelin?
What do laboratories study this blend for?
How is the lyophilized blend stored and reconstituted?
Loading full product details…